Change font size Change contrast


Oxular’s development pipeline includes treatments for prevalent retinal diseases, such as diabetic macular edema, and ocular cancers, plus programs for other rare and orphan conditions.

Our approach aims to minimize frequency of treatments, improve delivery and reduce side effects, while increasing therapeutic effectiveness.

Find out more about us